Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(11): 1252-1265, 2023 Nov.
Article
en En
| MEDLINE
| ID: mdl-37844597
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Carcinoma de Células Renales
/
Isquemia Encefálica
/
Accidente Cerebrovascular
/
Neoplasias Renales
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2023
Tipo del documento:
Article